###begin article-title 0
The BH3-only protein Bik/Blk/Nbk inhibits nuclear translocation of activated ERK1/2 to mediate IFNgamma-induced cell death
###end article-title 0
###begin p 1
###xml 32 49 32 49 <email xmlns:xlink="http://www.w3.org/1999/xlink">ytesfaig@lrri.org</email>
Correspondence to Y. Tesfaigzi: ytesfaig@lrri.org
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 547 550 531 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 544 550 528 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 568 571 552 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 565 571 549 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 921 924 897 900 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 913 924 893 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFN&#947;<sup>&#8722;/&#8722;</sup></italic>
###xml 931 934 907 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 928 934 904 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 184 189 <span type="species:ncbi:9606">human</span>
###xml 572 578 <span type="species:ncbi:10090">murine</span>
###xml 959 963 <span type="species:ncbi:10090">mice</span>
IFNgamma induces cell death in epithelial cells, but the mediator for this death pathway has not been identified. In this study, we find that expression of Bik/Blk/Nbk is increased in human airway epithelial cells (AECs [HAECs]) in response to IFNgamma. Expression of Bik but not mutant BikL61G induces and loss of Bik suppresses IFNgamma-induced cell death in HAECs. IFNgamma treatment and Bik expression increase cathepsin B and D messenger RNA levels and reduce levels of phospho-extracellular regulated kinase 1/2 (ERK1/2) in the nuclei of bik+/+ compared with bik-/- murine AECs. Bik but not BikL61G interacts with and suppresses nuclear translocation of phospho-ERK1/2, and suppression of ERK1/2 activation inhibits IFNgamma- and Bik-induced cell death. Furthermore, after prolonged exposure to allergen, hyperplastic epithelial cells persist longer, and nuclear phospho-ERK is more prevalent in airways of IFNgamma-/- or bik-/- compared with wild-type mice. These results demonstrate that IFNgamma requires Bik to suppress nuclear localization of phospho-ERK1/2 to channel cell death in AECs.
###end p 3
###begin p 4
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 204 209 <span type="species:ncbi:10090">mouse</span>
Abbreviations used in this paper: AB, Alcian blue; AEC, airway epithelial cell; BH, Bcl-2 homology; CT, control; DAP, death-associated protein; ERK, extracellular regulated kinase; HAEC, human AEC; MAEC, mouse AEC; shRNA, short hairpin RNA.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 92 110 88 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">Deiss et al., 1995</xref>
###xml 112 131 108 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">Ossina et al., 1997</xref>
###xml 133 149 129 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib63">Wen et al., 1997</xref>
###xml 151 173 147 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">Ruiz-Ruiz et al., 2000</xref>
###xml 175 197 171 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">Trautmann et al., 2000</xref>
###xml 199 220 195 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Horiuchi et al., 2006</xref>
###xml 292 304 288 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">Barber, 2000</xref>
###xml 527 545 515 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">Xiang et al., 2008</xref>
###xml 799 821 779 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib70">Yoshikawa et al., 2001</xref>
###xml 1001 1019 977 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib73">Zhang et al., 1997</xref>
###xml 1110 1132 1082 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">Trautmann et al., 2000</xref>
###xml 1281 1297 1249 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Shi et al., 2002</xref>
###xml 1299 1321 1267 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">Trautmann et al., 2002</xref>
###xml 1361 1376 1325 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">Tesfaigzi, 2006</xref>
###xml 1494 1510 1458 1474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Shi et al., 2002</xref>
###xml 1568 1590 1532 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Tesfaigzi et al., 2002</xref>
###xml 1592 1610 1556 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">Stout et al., 2007</xref>
###xml 1752 1768 1712 1728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Shi et al., 2002</xref>
###xml 1770 1789 1730 1749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">Pierce et al., 2006</xref>
###xml 1840 1857 1800 1817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib72">Youn et al., 2005</xref>
###xml 1236 1241 <span type="species:ncbi:9606">human</span>
Although it is well established that IFNgamma causes cell death in a variety of cell types (Deiss et al., 1995; Ossina et al., 1997; Wen et al., 1997; Ruiz-Ruiz et al., 2000; Trautmann et al., 2000; Horiuchi et al., 2006), the signal transduction downstream of STAT1 remains largely unknown (Barber, 2000). Unraveling the role of IFNgamma in apoptosis remains a challenge because IFNgamma may prime cells to apoptosis and through induction of many genes can concomitantly elicit an antiproliferative and a proliferative state (Xiang et al., 2008). The decision between life and death may depend on possible costimuli or the cell type. Enhanced expression and translocation of Diablo into the cytosol play a critical role in the promotion of IFNgamma-induced apoptosis of IFNgamma-sensitive B cells (Yoshikawa et al., 2001). Th1 cells that secrete high levels of IFNgamma are more susceptible to activation-induced cell death than Th2 cells because Th2 cells express Fas-associated phosphatase, FAP-1 (Zhang et al., 1997). In keratinocytes, IFNgamma induces apoptosis via increasing expression of Fas receptor (Trautmann et al., 2000), whereas the Fas ligand-Fas receptor pathway is not involved in the IFNgamma-induced death of primary human airway epithelial cells (AECs [HAECs]; Shi et al., 2002; Trautmann et al., 2002). IFNgamma induces cell death in AECs (Tesfaigzi, 2006) to remove hyperplastic epithelial cells after inflammation-induced epithelial cell hyperplasia by activating STAT1 (Shi et al., 2002), translocating Bax to the ER, and releasing ER calcium (Tesfaigzi et al., 2002; Stout et al., 2007). Disruption of the IFNgamma-induced elimination of hyperplastic epithelial cells can be the source for chronic mucous secretions in asthma (Shi et al., 2002; Pierce et al., 2006) or for neoplastic growth over prolonged periods (Youn et al., 2005).
###end p 6
###begin p 7
###xml 143 164 143 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">Lindsten et al., 2000</xref>
###xml 216 217 216 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 346 362 346 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">Wei et al., 2001</xref>
###xml 504 524 504 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">Adams and Cory, 1998</xref>
###xml 526 546 526 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Cryns and Yuan, 1998</xref>
###xml 548 577 548 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">Thornberry and Lazebnik, 1998</xref>
###xml 711 727 711 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">Oda et al., 2000</xref>
###xml 729 747 729 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">Letai et al., 2002</xref>
###xml 849 869 849 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">Coultas et al., 2002</xref>
###xml 871 899 871 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Opferman and Korsmeyer, 2003</xref>
###xml 1032 1050 1032 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">Cheng et al., 2001</xref>
###xml 1052 1069 1052 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">Naik et al., 2007</xref>
###xml 1071 1091 1071 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">Shimazu et al., 2007</xref>
###xml 1093 1112 1093 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib64">Willis et al., 2007</xref>
###xml 1224 1246 1224 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib60">Villunger et al., 2003</xref>
###xml 1281 1299 1281 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">Verma et al., 2001</xref>
###xml 1301 1320 1301 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">Lei and Davis, 2003</xref>
###xml 1446 1470 1446 1470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">Puthalakath et al., 2001</xref>
###xml 1472 1488 1472 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">Day et al., 2004</xref>
The Bcl-2 family of proteins consists of members with three to four Bcl-2 homology (BH) regions such as the proapoptotic proteins Bax and Bak (Lindsten et al., 2000) and the antiapoptotic members such as Bcl-2, Bcl-xL, and MCL-1. The interactions of these proteins are an essential gateway required for cell death in response to diverse stimuli (Wei et al., 2001) and under a wide variety of circumstances, suggesting that they act at a central control (CT) point in the pathway to apoptotic cell death (Adams and Cory, 1998; Cryns and Yuan, 1998; Thornberry and Lazebnik, 1998). Another group of Bcl-2 family members contains only the BH3 motif and displays some selectivity for multiple domain Bcl-2 members (Oda et al., 2000; Letai et al., 2002) and provides a link between various cell death initiators and the execution machinery of apoptosis (Coultas et al., 2002; Opferman and Korsmeyer, 2003). BH3-only proteins inactivate the antiapoptotic proteins and allow activation of the multidomain proapoptotic members Bax and Bak (Cheng et al., 2001; Naik et al., 2007; Shimazu et al., 2007; Willis et al., 2007). The proapoptotic activity of BH3-only molecules is kept in check by either p53-dependent transcriptional CT (Villunger et al., 2003), posttranslational modification (Verma et al., 2001; Lei and Davis, 2003), or by binding to the dynein light chain in myosin V filamentous actin and thereby being sequestered from binding to Bcl-2 (Puthalakath et al., 2001; Day et al., 2004).
###end p 7
###begin p 8
###xml 390 393 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 403 406 391 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik</italic>
###xml 366 371 <span type="species:ncbi:10090">mouse</span>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
###xml 854 859 <span type="species:ncbi:10090">mouse</span>
###xml 1201 1206 <span type="species:ncbi:10090">mouse</span>
Our goal for this study was to further characterize the IFNgamma-induced cell death in AECs by identifying the BH3-only proteins involved in this pathway. Bik/Blk/Nbk was consistently induced by IFNgamma, and its expression induced cell death. Loss of Bik but not p53, Bim, or Bax conferred resistance to IFNgamma but not to thapsigargin-induced cell death. Primary mouse AECs (MAECs) from p53- but not bik-deficient mice were protected from DNA damage-induced cell death. We demonstrate that the conserved Leu residue within the BH3 domain of Bik is crucial for its cell death-inducing activity by interacting with and suppressing the nuclear localization of phospho-extracellular regulated kinase 1/2 (ERK1/2) in MAECs and HAECs. Furthermore, loss of Bik was accompanied by increased nuclear phospho-ERK1/2 and sustained epithelial cell hyperplasia in mouse airways, and blocking activated ERK1/2 with U0126 suppressed cell death in response to IFNgamma treatment and Bik expression. Therefore, these experiments show that Bik is central in mediating IFNgamma-induced cell death by retaining activated ERK1/2 in the cytosol in cultured AECs and during resolution of hyperplastic epithelial cells in mouse airways.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
IFNgamma induces Bik expression to elicit cell death in AECs
###end title 10
###begin p 11
###xml 109 125 105 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Shi et al., 2002</xref>
###xml 181 203 177 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Tesfaigzi et al., 2002</xref>
###xml 205 223 201 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">Stout et al., 2007</xref>
###xml 716 724 704 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 799 807 783 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 631 635 <span type="species:ncbi:9696">Puma</span>
We have previously shown that proliferating but not resting HAECs undergo apoptosis in response to IFNgamma (Shi et al., 2002) and that Bax plays a role in this cell death pathway (Tesfaigzi et al., 2002; Stout et al., 2007). To identify which of the BH3-only proteins initiate IFNgamma-induced cell death upstream of Bax, primary HAECs and AALEB cells, a cell line derived from HAECs, were treated with IFNgamma for 12, 24, 48, 72, and 96 h, and the changed expression of all the BH3-only members of the Bcl-2 family of proteins was screened using quantitative RT-PCR. Significant induction was consistently observed for Bik, but Puma, Hrk, Bid, and Bad remained unchanged. Bik mRNA levels were induced at 24-96 h (Fig. 1 A), and Bik protein levels were increased at 24 h after IFNgamma treatment (Fig. 1 B) and remained elevated over 96 h (not depicted).
###end p 11
###begin p 12
###xml 0 79 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IFN&#947; treatment induces Bik by activating STAT1 to cause cell death in AECs.</bold>
###xml 419 422 407 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 414 422 402 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1<sup>+/+</sup></italic>
###xml 432 435 420 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 427 435 415 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1<sup>&#8722;/&#8722;</sup></italic>
###xml 681 685 665 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
###xml 786 790 770 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
IFNgamma treatment induces Bik by activating STAT1 to cause cell death in AECs. (A and B) HAECs were treated with IFNgamma for the indicated times, and Bik expression was analyzed by quantitative RT-PCR (A) and Western blotting (B). The relative standard curve method was used for analysis of unknown samples, and data are presented as fold change after averaging the DeltaCT values for the untreated samples. (C) STAT1+/+ and STAT1-/- MAECs were treated with IFNgamma for 24 h on Transwell culture inserts. Protein from harvested cells was immunoblotted with the indicated antibodies. (D) Detection of Bik in HBEC-2 cells infected with nothing (lane 1), Ad-Bik (lane 2), or Ad-BikL61G (lane 3) at 100 MOI by Western analysis. (E) HBEC-2 cells were infected with nothing, Ad-Bik, Ad-BikL61G, or Ad-GFP, and cells were counted 24 h after infection. (F) HBEC-2 cells were infected with a retroviral expression vector for Bik shRNA or an empty vector and 24 h later were treated with 50 ng/ml IFNgamma. Cells were harvested 48 h later for Western blot analysis with anti-Bik and antiactin antibodies, and cell counts were determined for IFNgamma-treated cells infected with a CT vector or Bik shRNA expression retroviruses. Data presented are means +/- SEM for three independent experiments. *, P < 0.05; statistically significant difference from the untreated CT.
###end p 12
###begin p 13
###xml 68 71 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 63 71 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1<sup>+/+</sup></italic>
###xml 81 84 81 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 76 84 76 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1<sup>&#8722;/&#8722;</sup></italic>
###xml 249 252 245 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 244 252 240 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1<sup>&#8722;/&#8722;</sup></italic>
###xml 272 275 268 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 267 275 263 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1<sup>+/+</sup></italic>
###xml 283 291 279 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 631 647 623 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Han et al., 1996</xref>
###xml 649 668 641 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Mathai et al., 2002</xref>
###xml 716 724 708 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
To determine whether Bik expression requires STAT1 activation, STAT1+/+ and STAT1-/- MAECs were treated with IFNgamma for 24 h, and cell extracts were analyzed for Bik expression. Results showed that Bik expression was significantly reduced in STAT1-/- compared with STAT1+/+ MAECs (Fig. 1 C). Similarly, compared with Flag-expressing HBEC-2 cells, a significant reduction in Bik expression was observed in cells expressing a Flag-tagged dominant-negative construct for STAT1 that was previously shown to suppress IFNgamma-induced cell death (unpublished data). However, p53, which has been shown to be important for inducing Bik (Han et al., 1996; Mathai et al., 2002), was not perceptibly affected in these cells (Fig. 1 C).
###end p 13
###begin title 14
The BH3 domain of Bik is crucial for inducing death in proliferating epithelial cells
###end title 14
###begin p 15
###xml 174 178 174 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
###xml 334 342 334 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 413 421 413 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 E</xref>
###xml 443 447 443 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
###xml 544 560 540 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Shi et al., 2002</xref>
###xml 1072 1080 1060 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 F</xref>
###xml 1233 1241 1217 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 F</xref>
To investigate the role of Bik and the importance of the BH3 domain in inducing cell death, we expressed Bik adenoviral expression vector for Bik (Ad-Bik), mutant Bik (Ad-BikL61G), or adenoviral expression vector for GFP (Ad-GFP) in the immortalized AEC line, HBEC-2, and HAECs using an adenoviral expression system at an MOI of 100 (Fig. 1 D). Ad-Bik expression reduced the number of HBEC-2 cells significantly (Fig. 1 E) compared with Ad-BikL61G- or Ad-GFP-infected cells with an equal amount of MOI. As was previously observed for IFNgamma (Shi et al., 2002), the ability of Bik to induce cell death was sensitive to cell growth conditions because confluent cultures of HBEC-2 cells or HAECs were unaffected by Ad-Bik infection, even though Bik expression was evident by Western blot analysis (unpublished data). To further investigate the role of Bik in IFNgamma-induced cell death, IFNgamma-induced Bik expression was suppressed in HAECs by infecting with a retroviral expression vector for Bik short hairpin RNA (shRNA), whereas CTs were infected with empty vector (Fig. 1 F). Suppression of IFNgamma-induced Bik expression resulted in a significantly increased number of cells compared with cells infected with CT retrovirus (Fig. 1 F).
###end p 15
###begin p 16
###xml 119 122 115 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 116 122 112 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 188 208 184 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">Coultas et al., 2004</xref>
###xml 323 326 315 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 320 326 312 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 334 337 326 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 331 337 323 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 479 482 467 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 476 482 464 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 497 500 485 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 494 500 482 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 508 516 496 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 675 678 655 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 672 678 652 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 685 693 665 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 710 713 690 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 707 713 687 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 775 778 755 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 772 778 752 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bim<sup>&#8722;/&#8722;</sup></italic>
###xml 785 788 765 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 782 788 762 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bax<sup>&#8722;/&#8722;</sup></italic>
###xml 902 905 874 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 899 905 871 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 913 921 885 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 449 455 <span type="species:ncbi:10090">murine</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
###xml 714 718 <span type="species:ncbi:10090">mice</span>
###xml 758 762 <span type="species:ncbi:10090">mice</span>
Overall, these studies showed that IFNgamma induces cell death in AECs through Bik, although a previous study using bik-/- mice had shown that Bik has no role in hematopoietic cell death (Coultas et al., 2004). To determine whether Bik deficiency confers resistance to IFNgamma-induced AEC death, we isolated MAECs from bik+/+ and bik-/- mice and placed them in culture on Transwell membranes. As expected, Bik expression was induced by recombinant murine IFNgamma at 24 h in bik+/+ but not in bik-/- MAECs (Fig. 2 A). Consistent with the idea that IFNgamma requires Bik to induce cell death, IFNgamma significantly reduced the number of MAECs from wild-type but not from bik-/- mice (Fig. 2 B). MAECs from p53-/- mice died similarly to those from wild-type mice, whereas bim-/- or bax-/- MAECs appeared to be even more susceptible to IFNgamma-induced cell death. IFNgamma induced Bik expression in p53-/- MAECs (Fig. 2 C), suggesting that p53 is not a crucial player in the IFNgamma-induced cell death process.
###end p 16
###begin p 17
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bik<sup>&#8722;/&#8722;</sup></italic>
###xml 0 58 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Bik<sup>&#8722;/&#8722;</sup></italic> MAECs are resistant to IFN&#947;-induced cell death.</bold>
###xml 110 113 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 107 113 103 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 173 176 165 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 170 176 162 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 227 230 219 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 224 230 216 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 235 238 227 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 232 238 224 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 243 246 235 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 240 246 232 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bax<sup>&#8722;/&#8722;</sup></italic>
###xml 251 254 243 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 248 254 240 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bim<sup>&#8722;/&#8722;</sup></italic>
###xml 431 434 419 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 428 434 416 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 439 442 427 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 436 442 424 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bax<sup>&#8722;/&#8722;</sup></italic>
###xml 447 450 435 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 444 450 432 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bim<sup>&#8722;/&#8722;</sup></italic>
###xml 512 515 500 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 509 515 497 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 624 627 610 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 621 627 607 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 782 785 764 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 779 785 761 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 790 793 772 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 787 793 769 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 889 892 870 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 886 892 867 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bik<sup>+/+</sup></italic>
###xml 900 903 881 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 897 903 878 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 1007 1010 987 990 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1004 1010 984 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 1018 1021 998 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1015 1021 995 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 1130 1133 1106 1109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1127 1133 1103 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bik<sup>&#8722;/&#8722;</sup></italic>
###xml 1191 1195 1167 1171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
###xml 355 361 <span type="species:ncbi:10090">murine</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
###xml 628 632 <span type="species:ncbi:10090">mice</span>
Bik-/- MAECs are resistant to IFNgamma-induced cell death. (A) Western blot analysis shows that MAECs from bik+/+ mice express Bik 24 h after IFNgamma treatment, whereas bik-/- MAECs did not. (B) Primary MAECs isolated from bik-/-, p53-/-, bax-/-, bim-/-, and wild-type mice were placed in culture on Transwell membranes treated with 50 ng/ml recombinant murine IFNgamma or were left untreated and counted 4 d later. MAECs from p53-/-, bax-/-, bim-/-, and wild-type mice showed significant reduction, whereas bik-/- AECs were unaffected. Data presented are means +/- SEM for three independent experiments. (C) MAECs from p53-/- mice were either left untreated or were treated with IFNgamma for 24 h, and protein extracts were analyzed for Bik expression by Western blotting. (D) p53-/-, bik-/-, and wild-type MAECs were treated with 0.5 muM adriamycin and counted at 0, 1, and 2 d. (E) Bik+/+ and bik-/- MAECs were treated with 1 muM thapsigargin, and cell viability was determined at 0, 1, and 2 d. (F) bik+/+ and bik-/- MAECs were treated with 50 ng/ml IFNgamma, and cell viability was determined at 0, 1, and 2 d. (G and H) Bik-/- MAECs were either infected with Ad-GFP, Ad-Bik, or Ad-BikL61G, and 24 h later protein extracts were analyzed for Bik expression by Western blotting (G) and cells were counted (H). Error bars indicate +/- SEM. *, P < 0.05; statistically significant difference from the untreated CT.
###end p 17
###begin p 18
###xml 259 262 255 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 256 262 252 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 296 304 292 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 310 313 306 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 307 313 303 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bik<sup>+/+</sup></italic>
###xml 321 324 317 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 318 324 314 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 378 386 374 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 450 469 446 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">Hamann et al., 1998</xref>
###xml 471 487 467 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Shi et al., 2002</xref>
###xml 533 536 529 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 530 536 526 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 544 547 540 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 541 547 537 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 820 823 800 803 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 817 823 797 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 858 866 838 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 F</xref>
###xml 1000 1003 976 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 997 1003 973 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 1076 1079 1052 1055 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1073 1079 1049 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 1130 1145 1106 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, G and H</xref>
We next determined whether Bik deficiency affected the response of MAECs to proapoptotic stimuli other than IFNgamma. Loss of Bik did not confer any protection on MAECs undergoing apoptosis after exposure to the DNA-intercalating agent adriamycin, whereas p53-/- MAECs were completely protected (Fig. 2 D). Bik+/+ and bik-/- MAECs were also equally susceptible to thapsigargin (Fig. 2 E). As was previously reported that HAECs are resistant to FasL (Hamann et al., 1998; Shi et al., 2002), treatment with FasL did not affect both bik-/- and bik+/+ MAECs (unpublished data). Therefore, loss of Bik did not sensitize MAECs to FasL-induced cell death. However, consistent with the described experiments, Bik deficiency completely protected MAECs from IFNgamma observed over a period of 48 h, whereas approximately50% of bik+/+ MAECs died over this time period (Fig. 2 F). To further confirm that Bik is crucial for IFNgamma-induced cell death, we reintroduced either wild-type Bik or mutant Bik into bik-/- MAECs using adenoviral infection and found significant cell death in bik-/- MAECs by expressing wild-type but not mutant Bik (Fig. 2, G and H).
###end p 18
###begin p 19
###xml 174 193 174 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">Vermes et al., 1995</xref>
###xml 381 389 377 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 688 692 676 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
###xml 719 727 707 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
Translocation of phosphatidylserine from the inner leaflet of the cell's membrane to the outer leaflet is an early event in apoptotic cells that allows binding to annexin V (Vermes et al., 1995). Treating HBEC-2 cells with IFNgamma for 48 h consistently showed a significant increase of cells that are positive for propidium iodide and annexin V FITC compared with nontreated CTs (Fig. 3 A). Similarly, the percentages of early and late apoptotic cells as determined by annexin V and propidium iodide staining were significantly increased from 5.5 +/- 0.8% to 23.6 +/- 2%, and the percentage of viable cells was reduced from 91.8 +/- 0.8% to 67.9 +/- 3.4% at 24 h of infection with Ad-BikL61G and Ad-Bik, respectively (Fig. 3 A). To ensure that cells were infected with equal titers of the adenoviral vectors, Bik expression was analyzed by Western blotting, and infection with Ad-GFP showed minimal cell death (unpublished data).
###end p 19
###begin p 20
###xml 0 82 0 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">INF&#947; and Bik induce annexin V positivity and expression of cathepsins B and D.</bold>
###xml 203 207 195 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
###xml 402 406 390 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
###xml 676 677 659 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 761 764 744 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 758 764 741 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 772 775 755 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 769 775 752 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 967 970 943 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 964 970 940 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 978 981 954 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 975 981 951 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
INFgamma and Bik induce annexin V positivity and expression of cathepsins B and D. (A) HBEC-2 cells were either left untreated, were treated with IFNgamma for 48 h, or were infected with Ad-Bik or Ad-BikL61G and stained for annexin V positivity. Representative figures of six independent experiments are shown. (B) HBEC-2 cells were treated with nothing or IFNgamma or were infected with Ad-GFP, Ad-BikL61G, or Ad-Bik, and mRNA levels for cathepsins B and D were assessed by RT-PCR. beta-Actin mRNA expression was used as a loading CT, and expression levels were compared with CTs. A representative figure and the quantification of data expressed as mean +/- SEM representing n = 3 for each group are shown. *, P < 0.05 compared with the respective CTs. (C) bik+/+ and bik-/- MAECs were treated with 50 ng/ml IFNgamma, and mRNA levels for cathepsins B and D were assessed by RT-PCR. beta-Actin mRNA expression was used as a loading CT. (D) Annexin V positivity of bik-/- and bik+/+ MAECs treated with 50 ng/ml IFNgamma. NT, not treated.
###end p 20
###begin p 21
###xml 265 283 253 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Deiss et al., 1996</xref>
###xml 285 302 273 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">Wang et al., 2000</xref>
###xml 411 415 395 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
###xml 600 604 580 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
###xml 626 634 606 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 718 726 694 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 754 762 730 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 789 792 765 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 786 792 762 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 810 813 786 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 807 813 783 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
If Bik is crucial for IFNgamma-induced cell death, we reasoned that the known downstream effectors for IFNgamma-induced cell death would be identically induced by Bik. Cathepsins B and D are increased in expression by IFNgamma and mediate the resulting cell death (Deiss et al., 1996; Wang et al., 2000). Therefore, HBEC-2 cells were treated with IFNgamma or nothing as a CT or were infected with Ad-Bik, Ad-BikL61G, or GFP (Ad-GFP), and expression of cathepsins B and D was analyzed by RT-PCR. Both cathepsins B and D were reproducibly induced by both IFNgamma and Ad-Bik but not by Ad-GFP or Ad-BikL61G or in untreated CTs (Fig. 3 B). In addition, treatment with IFNgamma increased expression of cathepsins B and D (Fig. 3 C) and annexin V positivity (Fig. 3 D) significantly more in bik+/+ compared with bik-/- MAECs, further confirming that Bik is a central mediator for this cell death pathway.
###end p 21
###begin title 22
Bik blocks nuclear translocation of activated ERK1/2 to cause cell death
###end title 22
###begin p 23
###xml 111 132 107 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Horiuchi et al., 2006</xref>
###xml 397 405 381 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 462 465 446 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 459 465 443 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 473 476 457 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 470 476 454 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 551 559 531 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 764 780 744 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">Lai et al., 2002</xref>
###xml 782 799 762 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">Chen et al., 2005</xref>
###xml 883 886 859 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 880 886 856 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 894 897 870 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 891 897 867 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 977 980 953 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 974 980 950 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 998 1001 974 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 995 1001 971 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 1009 1017 985 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 1169 1173 1145 1149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
###xml 1640 1644 1616 1620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
###xml 1661 1669 1637 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 1888 1892 1864 1868 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
###xml 1995 1999 1971 1975 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
###xml 2034 2042 2010 2018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 E</xref>
A previous study showed that IFNgamma-induced cell death of oligodendroglial cells requires ERK1/2 activation (Horiuchi et al., 2006). To determine the mechanisms of how Bik mediates IFNgamma-induced cell death, extracts from HBEC-2 cells treated with IFNgamma for 0, 1, 4, 8, 24, and 48 h were subjected to Western blot analysis. ERK1/2 was significantly activated 24 h after IFNgamma treatment (Fig. 4 A), but the extent of ERK1/2 activation was similar in bik+/+ and bik-/- MAECs when treated with IFNgamma for 24 h and Bik expression was evident (Fig. 4 B), suggesting that Bik was not mediating ERK1/2 activation. Previous studies had demonstrated that nuclear ERK activation causes cells to proliferate, although cytosolic ERK is associated with cell death (Lai et al., 2002; Chen et al., 2005). Therefore, we examined the distribution of phospho-ERK1/2 in IFNgamma-treated bik+/+ and bik-/- MAECs and found that activated ERK1/2 was reduced in the nuclear extract of bik+/+ compared with bik-/- MAECs (Fig. 4 C). To further confirm that Bik overexpression inhibits nuclear translocation of ERK1/2, primary HAECs were infected with nothing as a CT, Ad-Bik, Ad-BikL61G, or Ad-GFP, and the cytosolic and nuclear extracts were analyzed by Western blotting 48 h later. We had previously observed that leaving the medium unchanged for 48 h caused sustained activation of ERK1/2 in HAECs (unpublished data). Although phospho-ERK1/2 was detected in the cytosolic extracts from CT and Ad-Bik-infected cells, phospho-ERK1/2 was absent in the nuclear fraction of Ad-Bik-infected HAECs but present in CT cells transfected with Ad-GFP- and Ad-BikL61G-infected cells (Fig. 4 D). To investigate whether Bik binds to activated ERK1/2 to inhibit its nuclear translocation, we performed immunoprecipitation assays with proteins extracted from HBEC-2 that were infected with Ad-GFP, Ad-Bik, or Ad-BikL61G. Results showed that phospho-ERK1/2 is detected in pull-down products from Ad-Bik- but not from Ad-BikL61G- or Ad-GFP-infected HBEC-2 cells (Fig. 4 E), suggesting that Bik directly interacts with phospho-ERK1/2 to sequester ERK1/2 in the cytoplasm.
###end p 23
###begin p 24
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Bik binds to activated ERK1/2 and inhibits its nuclear translocation.</bold>
###xml 374 377 362 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 371 377 359 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 411 414 399 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 408 414 396 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 636 639 612 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 633 639 609 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 647 650 623 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 644 650 620 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 846 850 822 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
###xml 1245 1249 1221 1225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
###xml 1569 1572 1545 1548 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1566 1572 1542 1548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 1590 1593 1566 1569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1587 1593 1563 1569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 2564 2565 2526 2527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 415 419 <span type="species:ncbi:10090">mice</span>
###xml 479 485 <span type="species:ncbi:10090">murine</span>
###xml 1594 1598 <span type="species:ncbi:10090">mice</span>
Bik binds to activated ERK1/2 and inhibits its nuclear translocation. (A) HBEC-2 cells were treated with 50 ng/ml human recombinant IFNgamma, and ERK1/2 activation was assessed at 1, 4, 8, 24, and 48 h of IFNgamma treatment. The ratio of phospho-ERK1/2 to total ERK1/2 at different time points after IFNgamma treatment was quantified. (B) ERK1/2 activation in MAECs from bik+/+ mice compared with those from bik-/- mice after IFNgamma treatment. MAECs were treated with 50 ng/ml murine recombinant IFNgamma for 24 h, and protein extracts were analyzed for Bik expression and phospho-ERK1/2. (C) Nuclear extract from IFNgamma-treated bik+/+ and bik-/- MAECs was analyzed for activated ERK1/2. (D) Translocation of phospho-ERK1/2 is inhibited by Bik expression in primary HAECs. HAECs were either left untreated or were infected with Ad-Bik, Ad-BikL61G, or Ad-GFP at an MOI of 100, and ERK1/2 was activated by maintaining cells in unchanged media for 48 h. Nuclear and cytosolic extracts were analyzed for phospho-ERK1/2, total ERK1/2, Bik, lamin, and actin. The figure is representative of three independent experiments. (E) Bik interacts with phospho-ERK1/2. Cell lysates prepared from HBEC-2 cells infected with either Ad-GFP, Ad-Bik, or Ad-BikL61G were immunoprecipitated with anti-Bik antibody. The cell lysates (input) and immunoprecipitates were resolved by SDS-PAGE and analyzed by Western blotting using antibodies to Bik, phospho-ERK1/2, and total ERK1/2. (F) Representative photomicrographs and quantification showing that a higher percentage of MAECs from bik-/- compared with bik+/+ mice displays nuclear localization of activated ERK1/2. MAECs were treated with 50 ng/ml IFNgamma for 24 h, fixed in paraformaldehyde, and immunostained for phospho-ERK1/2. The percentage of nuclei with phospho-ERK was quantified from three independent experiments. Bar, 10 mum. (G) HBEC-2 cells were infected with 100 MOI Ad-Bik and were cotreated with 1 muM U0126, the ERK-specific inhibitor. Cells infected with Ad-Bik showed a 60% decline in total cell number, and this decline was diminished when the HBEC-2 cells were cotreated with 0.1 or 1 muM U0126. The corresponding Western blot of proteins extracted from cells infected with Ad-Bik and treated with U0126 to suppress ERK1/2 activation. (H) Cell counts and Western blot analysis of protein extracted from HBEC-2 cells that were left untreated or treated with IFNgamma either alone or with U0126. Treatment with 1 muM U0126 did not affect cell growth. NT, not treated. Error bars indicate group means +/- SEM (n = 4 different treatments per group). *, P < 0.05; significantly different from Ad-Bik-infected cells.
###end p 24
###begin p 25
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 120 126 120 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 167 170 167 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 164 170 164 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 211 219 207 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 F</xref>
###xml 569 577 565 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 G</xref>
###xml 741 749 737 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 G</xref>
###xml 898 906 886 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 H</xref>
Immunofluorescence staining showed that the percentage of cells with nuclear phospho-ERK1/2 was significantly higher in bik-/- MAECs compared with that observed in bik+/+ MAECs after 24 h of IFNgamma treatment (Fig. 4 F). These results demonstrate that expression of Bik suppresses nuclear translocation of activated ERK1/2 and that the conserved Leu residue in the BH3 domain of Bik is crucial for the inhibition of translocation. Activated ERK1/2 in the presence of Bik was proapoptotic because Ad-Bik-induced cell death was suppressed by the ERK1/2 inhibitor U0126 (Fig. 4 G). Western blot analysis showed that in the presence of U0126, the levels of activation of cytosolic ERK1/2 were dramatically reduced in AECs infected with Ad-Bik (Fig. 4 G). Similarly, U0126 significantly attenuated IFNgamma-induced reduction of cell numbers and suppressed IFNgamma-induced cytosolic ERK1/2 activation (Fig. 4 H). Together, these experiments demonstrate that IFNgamma through Bik inhibits nuclear translocation of activated ERK1/2 and that cytosolic ERK1/2 is proapoptotic.
###end p 25
###begin title 26
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
Bik mediates removal of hyperplastic epithelial cells in mouse airways
###end title 26
###begin p 27
###xml 233 255 233 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Tesfaigzi et al., 2002</xref>
###xml 403 421 399 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">Stout et al., 2007</xref>
###xml 558 561 546 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 550 561 542 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFN&#947;<sup>&#8722;/&#8722;</sup></italic>
###xml 569 572 557 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 566 572 554 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 633 636 617 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 625 636 613 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFN&#947;<sup>&#8722;/&#8722;</sup></italic>
###xml 719 722 703 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 716 722 700 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 822 837 802 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, A and B</xref>
###xml 934 937 910 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 926 937 906 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFN&#947;<sup>&#8722;/&#8722;</sup></italic>
###xml 939 947 915 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 956 959 932 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 953 959 929 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 961 976 937 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, B and C</xref>
###xml 1177 1180 1153 1156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1174 1180 1150 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 1203 1206 1179 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1200 1206 1176 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 1253 1268 1229 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, D and E</xref>
###xml 1532 1535 1504 1507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1529 1535 1501 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 1543 1546 1515 1518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1540 1546 1512 1518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 1656 1659 1628 1631 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1653 1659 1625 1631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 1667 1670 1639 1642 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1664 1670 1636 1642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 1750 1753 1722 1725 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1747 1753 1719 1725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 1790 1798 1762 1770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 F</xref>
###xml 1965 1968 1937 1940 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1962 1968 1934 1940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 1976 1979 1948 1951 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1973 1979 1945 1951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 573 577 <span type="species:ncbi:10090">mice</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
###xml 978 982 <span type="species:ncbi:10090">mice</span>
###xml 1068 1072 <span type="species:ncbi:10090">mice</span>
###xml 1181 1185 <span type="species:ncbi:10090">mice</span>
###xml 1207 1211 <span type="species:ncbi:10090">mice</span>
###xml 1334 1339 <span type="species:ncbi:10090">mouse</span>
###xml 1547 1551 <span type="species:ncbi:10090">mice</span>
###xml 1671 1675 <span type="species:ncbi:10090">mice</span>
###xml 1980 1985 <span type="species:ncbi:10090">mouse</span>
Repeated exposure to allergen results in proliferation and epithelial cell hyperplasia associated with the mucous phenotype; however, when mice are continuously exposed for periods beyond 10 d, epithelial cell hyperplasia decreases (Tesfaigzi et al., 2002). Our previous experiments showed that IFNgamma and STAT1 signaling are central for the resolution of allergen-induced epithelia cell hyperplasia (Stout et al., 2007). Because Bik was central for IFNgamma-induced AEC death, we investigated whether this resolution process would be abrogated in IFNgamma-/- and bik-/- mice. Interestingly, epithelial cell hyperplasia in IFNgamma-/- airways after 5 d of allergen exposure was reduced compared with wild-type and bik-/- mice, suggesting that IFNgamma plays a role in the allergen-induced proliferation of airway cells (Fig. 5, A and B). However, as expected, resolution of epithelial cell hyperplasia was abrogated in both IFNgamma-/- (Fig. 5 A) and bik-/- (Fig. 5, B and C) mice during 15 d of allergen exposure, although it was significantly reduced in wild-type mice. Furthermore, the number of mucous cells per millimeter of basal lamina was significantly reduced in bik+/+ mice compared with bik-/- mice during 12 and 15 d of allergen exposure (Fig. 5, D and E), confirming that Bik is central for IFNgamma-induced killing in mouse airways as was observed in cultured MAECs. The role of Bik in inhibiting nuclear translocation of ERK1/2 was investigated by assessing the distribution of phospho-ERK1/2 in lung tissues of bik+/+ and bik-/- mice at 5, 12, and 15 d of allergen exposure. Nuclear phospho-ERK1/2 was detected in airway cells of both bik+/+ and bik-/- mice exposed to allergen for 5 d but in significantly higher percentages in bik-/- airways at 12 and 15 d of exposure (Fig. 5 F). Interestingly, primarily the mucus-containing cells showed immunostaining for nuclear phospho-ERK1/2. Total ERK1/2 was found to be distributed similarly in both bik+/+ and bik-/- mouse lungs after exposure to allergen for 5, 12, or 15 d. These findings show that Bik expression suppresses nuclear translocation of phospho-ERK1/2 in airways when resolution of hyperplastic epithelial cells occurs.
###end p 27
###begin p 28
###xml 0 144 0 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IFN&#947; and Bik are crucial for the resolution of epithelial cell hyperplasia and mucous cell metaplasia during prolonged exposure to allergen.</bold>
###xml 740 743 732 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 754 757 746 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 751 757 743 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 856 859 846 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 853 859 843 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 868 871 858 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 865 871 855 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 996 999 986 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 993 999 983 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 1014 1017 1004 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1011 1017 1001 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 1121 1124 1111 1114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1118 1124 1108 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 1139 1142 1129 1132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1136 1142 1126 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 1188 1191 1178 1181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1185 1191 1175 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 1199 1202 1189 1192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1196 1202 1186 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 1250 1251 1238 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1387 1390 1375 1378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1384 1390 1372 1378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 1398 1401 1386 1389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1395 1401 1383 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 1494 1497 1482 1485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1491 1497 1479 1485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 1598 1599 1584 1585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1719 1722 1705 1708 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1716 1722 1702 1708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 1730 1733 1716 1719 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1727 1733 1713 1719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 145 149 <span type="species:ncbi:10090">Mice</span>
###xml 295 300 <span type="species:ncbi:10090">mouse</span>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
###xml 762 766 <span type="species:ncbi:10090">mice</span>
###xml 883 887 <span type="species:ncbi:10090">mice</span>
###xml 1143 1147 <span type="species:ncbi:10090">mice</span>
###xml 1203 1207 <span type="species:ncbi:10090">mice</span>
###xml 1256 1260 <span type="species:ncbi:10090">mice</span>
###xml 1402 1406 <span type="species:ncbi:10090">mice</span>
###xml 1498 1502 <span type="species:ncbi:10090">mice</span>
###xml 1604 1608 <span type="species:ncbi:10090">mice</span>
###xml 1734 1738 <span type="species:ncbi:10090">mice</span>
IFNgamma and Bik are crucial for the resolution of epithelial cell hyperplasia and mucous cell metaplasia during prolonged exposure to allergen. Mice were immunized with ovalbumin/alum on days 1 and 7 and were exposed to ovalbumin aerosols for 5, 12, or 15 d. After sacrifice, the lungs of each mouse were fixed under constant pressure perfusion and cut in 4-mm slices from distal to caudal. Slices were embedded in paraffin, and tissue sections were stained with hematoxylin and eosin or AB/periodic acid Schiff to count the total cell number or mucous cell per millimeter of basal lamina, respectively. (A and B) The number of epithelial cells per millimeter of basal lamina was significantly reduced in wild-type mice but not in IFNgamma-/- (A) or bik-/- (B) mice at 15 d of exposure. Error bars indicate +/- SEM. (C) Representative micrographs from bik+/+- and bik-/--sensitized mice exposed to allergen for 5, 12, and 15 d display that the density of epithelial cell nuclei is reduced in bik+/+ but not in bik-/- airways. (D) The number of mucous cells per millimeter of basal lamina was significantly reduced in bik+/+ but not in bik-/- mice. (E) Representative micrographs from bik+/+ and bik-/- mice. Error bars indicate group means +/- SEM (n = 5 mice per group). (F) Representative photomicrographs and quantification showing that activated ERK1/2 is found in the nuclei in bik+/+ and bik-/- mice exposed to allergen for 5 d, but nuclear phospho-ERK is only observed in airways of bik-/- mice at 12 and 15 d. Arrows denote nuclear phospho-ERK1/2. Error bars indicate group means +/- SEM (n = 3 mice/group). Representative photomicrographs showing that total ERK1/2 is uniformly distributed in airways from bik+/+ and bik-/- mice exposed to allergen for 5, 12, and 15 d. *, P < 0.05; significantly different from wild-type CTs.
###end p 28
###begin title 29
Discussion
###end title 29
###begin title 30
IFNgamma-induced Bik expression and cell death requires STAT1 but is independent of p53
###end title 30
###begin p 31
###xml 141 144 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 136 144 128 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1<sup>&#8722;/&#8722;</sup></italic>
###xml 301 319 285 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">Stout et al., 2007</xref>
###xml 364 367 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 361 367 345 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 482 485 466 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 477 485 461 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1<sup>&#8722;/&#8722;</sup></italic>
###xml 492 510 476 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">Stout et al., 2007</xref>
###xml 837 860 821 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">Bromberg and Chen, 2001</xref>
###xml 920 938 904 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib57">Verma et al., 2000</xref>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
Our studies suggest that IFNgamma-induced activation of STAT1 causes Bik expression because IFNgamma failed to induce Bik expression in STAT1-/- MAECs, and the same truncation mutant of STAT1 that reduced IFNgamma-induced Bik expression also significantly reduced IFNgamma-induced cell death of AECs (Stout et al., 2007). The findings from the present study in bik-/- mice together with our previous findings that allergen-induced airway epithelial hyperplasia is sustained in STAT1-/- mice (Stout et al., 2007) places STAT1 activation upstream of Bik. Whether STAT1 activation leads to increased Bik promoter activity or causes stabilization of Bik mRNA is currently unclear. Support for direct interaction and activation of the Bik promoter by STAT1 could be based on the presence of seven STAT-binding consensus sequences, TTNCNNNAA (Bromberg and Chen, 2001), including two tandem sites within the core Bik promoter (Verma et al., 2000). However, our attempts to stimulate a Bik promoter luciferase construct with IFNgamma were not successful, suggesting that other transcription factors or mRNA stability may play a critical role in the induction of Bik expression by IFNgamma. Overall, the findings suggest that although STAT1 may affect many signaling pathways in vivo, its activation requires Bik expression to channel the apoptotic effect.
###end p 31
###begin p 32
###xml 135 138 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 132 138 128 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 373 376 357 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 370 376 354 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 591 610 571 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Mathai et al., 2002</xref>
Several observations show that the pathway by which IFNgamma induces cell death does not involve the p53 pathway. (1) Resistance of bik-/- MAECs to IFNgamma did not include the resistance to adriamycin that is mediated by DNA damage and p53 activation. (2) During IFNgamma-induced cell death, p53 levels were not affected in AECs. (3) IFNgamma induced Bik expression in p53-/- MAECs, suggesting that IFNgamma does not require p53 to induce Bik expression and cell death. Similarly, others have reported that Bik mediates cell death in the p53-deficient H1299 cells and does not require p53 (Mathai et al., 2002).
###end p 32
###begin title 33
Loss of Bik mediates resistance to IFNgamma but not to other cell death inducers
###end title 33
###begin p 34
###xml 61 80 57 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Mathai et al., 2005</xref>
###xml 175 193 171 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">Stout et al., 2007</xref>
###xml 311 333 303 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Tesfaigzi et al., 2002</xref>
###xml 343 346 335 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 340 346 332 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bax<sup>&#8722;/&#8722;</sup></italic>
###xml 467 488 455 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">Lindsten et al., 2000</xref>
###xml 490 506 478 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">Wei et al., 2001</xref>
IFNgamma induces Bik expression that is localized to the ER (Mathai et al., 2005), translocates Bax to the ER, and elicits ER stress as shown by release of ER calcium stores (Stout et al., 2007) by JNK activation and induction of CHOP levels (unpublished data). Bax plays a role in IFNgamma-induced cell death (Tesfaigzi et al., 2002), but bax-/- MAECs succumb to IFNgamma treatment, suggesting that Bak can substitute for the loss of Bax as was reported previously (Lindsten et al., 2000; Wei et al., 2001). In fact, data from the present studies suggest that loss of Bim or Bax may sensitize MAECs more to IFNgamma-induced cell death. Future studies need to investigate the role of Bim and Bax in the IFNgamma-induced expression of Bik and/or the ER-stress pathway.
###end p 34
###begin p 35
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bik<sup>&#8722;/&#8722;</sup></italic>
###xml 148 150 144 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 172 174 168 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 410 412 402 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 591 606 579 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Fu et al., 2007</xref>
###xml 725 740 713 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib66">Xu et al., 2005</xref>
###xml 883 903 871 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">Shimazu et al., 2007</xref>
Bik-/- MAECs are resistant to IFNgamma-induced ER stress, although they are sensitive to thapsigargin, a selective inhibitor of the ER-associated Ca2+-ATPase that allows Ca2+ to flow from the ER lumen into the cytoplasm. This sensitivity may be the result of IFNgamma causing activation of ER stress and calcium release by mechanisms different from those induced by thapsigargin or because the ER-associated Ca2+-ATPase may be downstream of Bik. IFNgamma and Bik-induced ER stress may be caused by the inactivation of GRP78 (BiP), an ER-associated protein that has antiapoptotic properties (Fu et al., 2007). Bik binds to GRP78 and allows the release of the critical transmembrane ER signaling proteins PERK, Ire1, and ATF6 (Xu et al., 2005). Protein shutdown caused by the bacterial toxin MazF or cycloheximide was also shown to require Bik to mediate cell death in TRex-293 cells (Shimazu et al., 2007). It is possible that inhibition of protein synthesis causes Bik expression by blocking the proteasome degradation system and results in massive ER stress through the GRP78 system.
###end p 35
###begin title 36
Bik blocks nuclear translocation of activated ERK1/2 to cause cell death
###end title 36
###begin p 37
###xml 200 221 192 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Horiuchi et al., 2006</xref>
###xml 292 295 284 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 289 295 281 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/+</sup></italic>
###xml 303 306 295 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 300 306 292 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 1203 1214 1187 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">Kolch, 2005</xref>
###xml 1321 1338 1305 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">Chen et al., 2005</xref>
###xml 1487 1505 1467 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">Deiss et al., 1995</xref>
###xml 1507 1532 1487 1512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">Levy-Strumpf et al., 1997</xref>
###xml 1934 1951 1910 1927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">Boyd et al., 1995</xref>
###xml 2021 2052 1997 2028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">Elangovan and Chinnadurai, 1997</xref>
###xml 1639 1644 <span type="species:ncbi:9606">human</span>
In HAECs, IFNgamma activated ERK1/2 24 h after treatment, which coincides with the time of Bik expression. ERK1/2 activation was also associated with IFNgamma-induced death in oligodendroglial cells (Horiuchi et al., 2006). Because ERK1/2 activation was similar in cytosolic extracts from bik+/+ and bik-/- MAECs, we started to analyze whether Bik may affect the localization of phospho-ERK1/2. Both Western blot and immunofluorescence analyses confirmed that the presence of nuclear ERK1/2 was suppressed when Bik was expressed. Not only IFNgamma- but also starvation-induced phospho-ERK1/2 was inhibited from translocating to the nucleus when Bik was present. The conserved Leu residue in the BH3 domain that was crucial for Bik-induced cell death was also crucial for interacting and inhibiting phospho-ERK1/2 translocation. Furthermore, inhibition of ERK1/2 using U0126 suppressed IFNgamma- and Bik-induced cell death, suggesting that cytosolic ERK1/2 is proapoptotic, whereas nuclear ERK1/2 promotes growth in AECs. The biological consequence of ERK activation in a given cell may be determined by the cell-specific cytosolic or nuclear substrates. ERK is generally considered to be antiapoptotic (Kolch, 2005) but can function as a stimulator of apoptosis in cells expressing death-associated protein (DAP) kinase (Chen et al., 2005), a kinase that promotes the cytoplasmic retention of ERK1/2. DAP-kinase was isolated from HeLa cells as a mediator of IFNgamma-induced cell death (Deiss et al., 1995; Levy-Strumpf et al., 1997), but its role in affecting the BH3-only proteins is not known. DAP-kinase is constitutively expressed in human HAECs and MAECs (unpublished data). Therefore, IFNgamma-induced ERK1/2 activation and Bik expression may initiate a feedback loop that initiates DAP-kinase-mediated cytoplasmic retention of ERK1/2 to promote the amplification of proapoptotic signals. Bik was shown to interact with Bcl-2 (Boyd et al., 1995), but this interaction is not sufficient for its apoptotic function (Elangovan and Chinnadurai, 1997). The present studies show that the proapoptotic function of Bik stems from its ability to inhibit nuclear translocation of phospho-ERK1/2.
###end p 37
###begin p 38
###xml 271 287 271 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib69">Yan et al., 2003</xref>
###xml 399 415 399 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib68">Yan et al., 2000</xref>
###xml 417 437 417 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib67">Yan and Sloane, 2003</xref>
###xml 522 544 522 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">Cavailles et al., 1993</xref>
The mechanisms of how Bik expression may induce expression of cathepsins B and D are unclear. Cathepsin B contains a TATA-less promoter but an E box that allows the formation of a transcription initiation complex involving the upstream stimulatory factors USF1 and ISF2 (Yan et al., 2003). Other transcription factors, including Ets1, Sp1, and EBS, regulate expression at two alternative promoters (Yan et al., 2000; Yan and Sloane, 2003). The TATA-containing promoter of cathepsin D is regulated by the hormone estrogen (Cavailles et al., 1993). Future studies will investigate whether Bik regulates expression of these mRNAs by reducing nuclear translocation of phospho-ERK1/2 that may have an inhibitory effect on these promoters or by increasing cytosolic phospho-ERK1/2 and prolonging mRNA half-life.
###end p 38
###begin title 39
IFNgamma can be proliferative but requires Bik to channel death
###end title 39
###begin p 40
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 100 103 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 92 103 92 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFN&#947;<sup>&#8722;/&#8722;</sup></italic>
###xml 289 292 277 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 281 292 273 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFN&#947;<sup>&#8722;/&#8722;</sup></italic>
###xml 300 303 288 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 297 303 285 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 380 399 364 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">Hansen et al., 1999</xref>
###xml 401 422 385 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">Randolph et al., 1999</xref>
###xml 424 442 408 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">Xiang et al., 2008</xref>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 562 568 <span type="species:ncbi:10090">murine</span>
###xml 637 642 <span type="species:ncbi:9606">human</span>
###xml 683 688 <span type="species:ncbi:9606">human</span>
###xml 693 699 <span type="species:ncbi:10090">murine</span>
Exposure to allergen caused more AEC hyperplasia in bik-/- and wild-type mice compared with IFNgamma-/- mice, suggesting that IFNgamma plays a role in the proliferation of epithelial cells. However, once the hyperplastic stage was established, the resolution was abrogated in both IFNgamma-/- and bik-/- mice. Such a double-sided effect for IFNgamma has been previously reported (Hansen et al., 1999; Randolph et al., 1999; Xiang et al., 2008); however, this study demonstrates that IFNgamma requires Bik to channel its cell death-inducing activity. So far, the murine Bik has only been suggested to represent a homologous equivalent of human Bik. The present studies show a role of human and murine Bik as the main mediator for IFNgamma-induced cell death and, therefore, suggest that they are functionally homologous.
###end p 40
###begin p 41
###xml 153 173 153 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">Coultas et al., 2004</xref>
###xml 183 186 183 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 180 186 180 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>&#8722;/&#8722;</sup></italic>
###xml 551 571 547 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">Coultas et al., 2004</xref>
###xml 994 1015 990 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">Bouillet et al., 2002</xref>
###xml 1031 1050 1027 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">Enders et al., 2003</xref>
###xml 1122 1141 1118 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">Pierce et al., 2006</xref>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
Although Bik is expressed in the liver, lung, heart, and kidneys and in granulocytes, macrophages, and developing as well as mature T and B lymphocytes (Coultas et al., 2004), the bik-/- mice develop and age normally, suggesting that IFNgamma-induced cell killing is not required during normal development under injury- and pathogen-free conditions. Loss of Bik conferred no protection to mature T and B cells from spontaneous death in culture, from treatment with dexamethasone or etoposide, or from cytokine starvation of mitogen-activated B cells (Coultas et al., 2004). Bik inducing death in AECs rather than hematopoietic cells may result from airway cells expressing other genes such as DAP-kinase to facilitate Bik-mediated suppression of nuclear translocation of phospho-ERK1/2. The cell type-specific effect of BH3-only domain proteins is further supported by our previous studies showing that Bim, an essential initiator of apoptosis in negative selection of autoreactive thymocytes (Bouillet et al., 2002), and B cells (Enders et al., 2003), are not involved in the resolution of airway epithelial hyperplasia (Pierce et al., 2006).
###end p 41
###begin p 42
###xml 688 708 680 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">Keenan et al., 1982a</xref>
###xml 709 710 701 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">b</xref>
###xml 711 712 703 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">c</xref>
###xml 764 786 756 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">Tesfaigzi et al., 2004</xref>
###xml 1085 1101 1073 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">Lai et al., 2002</xref>
###xml 1518 1534 1506 1522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Han et al., 1996</xref>
###xml 1536 1555 1524 1543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Mathai et al., 2002</xref>
###xml 140 145 <span type="species:ncbi:10090">mouse</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
###xml 1615 1633 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The present studies show that loss of Bik or IFNgamma leads to sustained epithelial cell hyperplasia after allergen-induced inflammation in mouse airways. In addition, proliferating rather than nonproliferating, resting AECs are prone to undergo cell death in response to IFNgamma treatment or Bik overexpression. Therefore, Bik is ineffective in inducing cell death in confluent airway epithelial cultures (unpublished data). Primarily the mucus-containing cells showed nuclear phospho-ERK1/2 in lung tissues of mice exposed to allergen. Several studies have shown that after injury to the airway epithelium, a large proportion of the hyperplastic and cycling cells are secretory cells (Keenan et al., 1982a,b,c). Because mucous cells are the hyperplastic cells (Tesfaigzi et al., 2004), they may be by default susceptible to cell death and elimination in vivo during resolution. Susceptibility of proliferating cells to IFNgamma or Bik-induced cell death may be a mechanism to selectively target hyperplastic epithelial cells that in airways usually represent mucus-producing cells (Lai et al., 2002). This selective elimination of only hyperplastic cells may ensure that resting AECs maintain the barrier function of the airway epithelium, may allow the CT of mucus production, and may prevent the development of cancerous lesions. Therefore, restoring Bik expression may be useful for eliminating hyperplastic airway cells. Bik was first identified as a protein that interacts with the adenoviral protein E1B 19K (Han et al., 1996; Mathai et al., 2002). The reason for E1B 19K or the viral homologue encoded by Epstein-Barr virus, BHRF1, singling out Bik for inhibition may be to sustain the viability of the host cells and promote replication and release of virus particles.
###end p 42
###begin p 43
###xml 80 84 <span type="species:ncbi:10090">mice</span>
In summary, our analyses of HAECs and MAECs in culture and in airways of intact mice identify Bik as the central mediator of IFNgamma-induced apoptosis. Furthermore, we provide evidence that Bik induces cell death by inhibiting nuclear translocation of activated ERK1/2 in a pathway that is independent of p53.
###end p 43
###begin title 44
Materials and methods
###end title 44
###begin title 45
Animals
###end title 45
###begin p 46
###xml 54 57 54 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 51 57 51 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53<sup>+/&#8722;</sup></italic>
###xml 315 318 315 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 312 318 312 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bax<sup>+/&#8722;</sup></italic>
###xml 323 326 323 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 320 326 320 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bim<sup>+/&#8722;</sup></italic>
###xml 335 338 335 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 332 338 332 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik<sup>+/&#8722;</sup></italic>
###xml 517 520 517 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 514 520 514 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bax<sup>+/+</sup></italic>
###xml 528 531 528 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 525 531 525 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bax<sup>&#8722;/&#8722;</sup></italic>
###xml 536 539 536 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 533 539 533 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53<sup>+/+</sup></italic>
###xml 547 550 547 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 544 550 544 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 559 562 559 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 556 562 556 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bim<sup>&#8722;/&#8722;</sup></italic>
###xml 571 574 571 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 568 574 568 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bim<sup>+/+</sup></italic>
###xml 579 582 579 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik</italic>
###xml 582 585 582 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 591 594 591 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bik</italic>
###xml 594 597 594 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 784 804 784 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">Coultas et al., 2004</xref>
###xml 812 815 812 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 807 815 807 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1<sup>&#8722;/&#8722;</sup></italic>
###xml 1221 1243 1221 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Tesfaigzi et al., 2002</xref>
###xml 1347 1363 1347 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Shi et al., 2002</xref>
###xml 1492 1508 1492 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Shi et al., 2002</xref>
###xml 1727 1754 1727 1754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Harkema and Hotchkiss, 1991</xref>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 107 111 <span type="species:ncbi:10090">Mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
###xml 1163 1167 <span type="species:ncbi:10090">mice</span>
Male-specific pathogen-free wild-type C57BL/6J and p53+/- mice were purchased from The Jackson Laboratory. Mice were housed in isolated cages under specific pathogen-free conditions. After a 14-d quarantine period, mice were acclimatized for 8 d and entered into the experimental protocol at 8-10 wk of age. The bax+/-, bim+/-, and bik+/- mice on C57BL/6 background were provided by S. Korsmeyer (Dana Farber Research Institute, Boston, MA) and A. Strasser (Walter and Eliza Hall Institute, Melbourne, Australia). Bax+/+ and bax-/-, p53+/+ and p53-/-, and bim-/- with bim+/+ and bik+/+ with bik-/- littermates were bred from the respective heterozygote mice at the Lovelace Respiratory Research Institute under specific pathogen-free conditions and genotyped as described previously (Coultas et al., 2004). STAT1-/- on C57BL/6 background were purchased from Taconic. All experiments were approved by the Institutional Animal Care and Use Committee and were performed at the Lovelace Respiratory Research Institute, a facility approved by the Association for the Assessment and Accreditation for Laboratory Animal Care International. Sensitization and exposure of mice to ovalbumin were performed as described previously (Tesfaigzi et al., 2002). Preparation of lung tissues for histopathological examination was performed as described previously (Shi et al., 2002). Tissue sections were stained with Alcian blue (AB) and periodic acid Schiff or hematoxylin and eosin as described previously (Shi et al., 2002). The number of AB-positive cells per millimeter of basal lamina was quantified using a light microscope (BH-2; Olympus) equipped with the Image analysis system (National Institutes of Health) as described previously (Harkema and Hotchkiss, 1991).
###end p 46
###begin title 47
Cells
###end title 47
###begin p 48
###xml 92 93 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 136 152 136 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib71">You et al., 2002</xref>
###xml 501 522 501 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">Lundberg et al., 2002</xref>
###xml 524 544 524 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">Ramirez et al., 2004</xref>
###xml 665 681 665 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Shi et al., 2002</xref>
MAECs were harvested and cultured on Transwell membranes (Corning) after seeding with 4 x 104 or 9 x 104 cells as previously described (You et al., 2002). Cell viability was determined by trypan blue exclusion. Primary HAECs were purchased from Cambrex Bio Science Walkersville, Inc. The immortalized HAECs, AALEB, and HBEC-2 cells provided by S. Randell (University of North Carolina Chapel Hill, Chapel Hill, NC) and J. Shay (University of Texas Southwestern, Dallas, TX) were described previously (Lundberg et al., 2002; Ramirez et al., 2004). Cells were maintained in bronchial epithelial growth medium supplemented with growth factors as described previously (Shi et al., 2002).
###end p 48
###begin p 49
###xml 45 49 45 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
###xml 172 191 172 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Mathai et al., 2002</xref>
Adenoviral expression vectors for Bik and BikL61G were provided by G. Shore (McGill University, Montreal, Quebec, Canada), and cells were infected as described previously (Mathai et al., 2002). The MAPK extracellular signal-regulated kinase inhibitor 4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio) butadiene (U0126) was purchased from EMD. The doxorubicin hydrochloride (adriamycin) was purchased from Thermo Fisher Scientific, and thapsigargin was purchased from Tocris Bioscience. Viability was assessed by trypan blue exclusion.
###end p 49
###begin title 50
Retroviral silencing with Bik shRNA
###end title 50
###begin p 51
###xml 437 442 <span type="species:ncbi:9606">human</span>
Retroviral silencing vector encoding for Bik shRNA and the CT vector were purchased from Origene Technologies, Inc. The suppressing effect of the shRNA was established in HBEC-2 cells, and amplification and purification of plasmid DNA and packaging of the retroviral particles in Phoenix cells were performed as specified by the manufacturer's instructions. After infection with Bik or CT shRNAs, HBEC-2 cells were treated with 50 ng/ml human recombinant IFNgamma, and 48 h later cells were harvested for Western blot analysis.
###end p 51
###begin title 52
RT-PCR
###end title 52
###begin p 53
###xml 615 635 606 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">Schwalm et al., 2008</xref>
For quantitative RT-PCR, the primer/probe sets (Applied Biosystems) were distributed into each well in duplicates, and target mRNAs were amplified by PCR in 20-mul reactions. Preamplification efficiency was assessed by performing amplification of nonamplifed cDNA with TaqMan Gene Expression Assays (Applied Biosystems). For all reactions, CT values >37 were eliminated for evaluation of preamplification efficiency. Uniform preamplification was demonstrated by a DeltaDeltaCT value of -1.5 to 1.5 when comparing the CT values of each gene amplified from preamplified and nonamplified cDNA as described previously (Schwalm et al., 2008). Because all results were derived from the linear amplification curve, the use of the DeltaDeltaCT method ensures that only mRNA amplification within the linear range was compared.
###end p 53
###begin p 54
###xml 334 351 334 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Dong et al., 2001</xref>
###xml 353 375 353 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">Tsukamoto et al., 2006</xref>
###xml 229 234 <span type="species:ncbi:9606">human</span>
###xml 239 245 <span type="species:ncbi:10090">murine</span>
For semiquantitative RT-PCR, total RNA was extracted from HBEC-2 cells with TRIZOL (TRI Reagent; Invitrogen), first-strand cDNA was synthesized using an oligo(dT) primer and Omniscript reverse transcription (QIAGEN), and PCR for human and murine cathepsins B and D was conducted using the primers and conditions described previously (Dong et al., 2001; Tsukamoto et al., 2006). Amplified PCR products were quantified via densitometry using Fluor-S-Max Imager and Quantity One software (Bio-Rad Laboratories). Band intensities were normalized with the corresponding band intensities for beta-actin.
###end p 54
###begin title 55
Immunofluorescence and immunohistochemistry
###end title 55
###begin p 56
###xml 180 199 180 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">Harris et al., 2005</xref>
###xml 509 527 509 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">Stout et al., 2007</xref>
###xml 265 271 <span type="species:ncbi:9986">rabbit</span>
###xml 304 310 <span type="species:ncbi:9986">rabbit</span>
###xml 401 405 <span type="species:ncbi:9925">goat</span>
###xml 411 417 <span type="species:ncbi:9986">rabbit</span>
Lung tissue sections were deparaffinized, rehydrated, washed, and, after antigen retrieval, incubated with the respective primary and secondary antibodies as described previously (Harris et al., 2005). Procedures for detection of ERK1/2 by immunofluorescence using rabbit antiphospho-ERK1/2 antibody and rabbit anti-ERK1/2 antibody (Cell Signaling Technology) at a 1:100 dilution and with a secondary goat anti-rabbit conjugated to Alexa Fluor 647 and the counterstain with Hoechst were described previously (Stout et al., 2007). Immunofluorescence was imaged using Axioplan 2 (Carl Zeiss, Inc.) with a Plan-Aprochromal 63x/1.4 oil objective and a charge-coupled device camera (SensiCAm; PCO), and the acquisition software used was digital microscopy software (Slidebook 4.2; Intelligent Imaging Innovation). Immunohistochemical stains were imaged using a microscope (Eclipse E600W; Nikon) with a Plan Fluor 60x NA 0.85 objective and a digital camera (DXM1200F; Nikon) with ACT-1 acquisition software (version 2.62; Nikon).
###end p 56
###begin title 57
Western blot analysis
###end title 57
###begin p 58
###xml 88 110 88 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Tesfaigzi et al., 2002</xref>
###xml 419 437 419 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">Stout et al., 2007</xref>
###xml 476 480 <span type="species:ncbi:9925">goat</span>
###xml 544 550 <span type="species:ncbi:9986">rabbit</span>
###xml 584 590 <span type="species:ncbi:9986">rabbit</span>
###xml 881 886 <span type="species:ncbi:10090">mouse</span>
Protein lysates were prepared and analyzed by Western blotting as described previously (Tesfaigzi et al., 2002). Cytosolic and nuclear fractions were prepared by lysing cells in NP-40 to obtain the cytosolic fraction and extracting the nuclear proteins with a hypertonic extraction buffer (50 mM Hepes, pH 7.8, 50 mM KCl, and 300 mM NaCl) in the presence of protease and phosphatase inhibitors as described previously (Stout et al., 2007). The following antibodies were used: goat anti-Bik polyclonal antibody (Santa Cruz Biotechnology, Inc.), rabbit antiphospho-ERK1/2 antibody, and rabbit anti-ERK1/2 antibody (Cell Signaling Technology). Total ERK1/2 was detected with anti-ERK1/2 antibodies (1:1,000) in the same membrane used for antiphospho-ERK1/2 and total ERK1/2 antibodies, respectively, after deprobing. Equal protein loading was confirmed by subsequent probing with the mouse monoclonal antibody against actin (Santa Cruz Biotechnology, Inc.).
###end p 58
###begin title 59
Pull-down assay
###end title 59
###begin p 60
###xml 331 335 330 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">L61G</sup>
A size X protein A immunoprecipitation kit (Thermo Fisher Scientific) was used to cross-link 50 mug of purified anti-Bik antibody to protein A beads using disuccinmidyl suberate as described by the manufacturer. Bik-associated proteins were immunoprecipitated by incubating protein lysates prepared from Ad-GFP-, Ad-Bik-, or Ad-BikL61G-infected HBEC-2 cells with gentle mixing at 4degreesC overnight. After repeated washes, proteins bound to the Bik antibody on beads were eluted with 0.2 ml of ImmunoPure Elution buffer (Thermo Fisher Scientific) and analyzed by Western blotting and antiphospho-ERK1/2 and anti-Bik antibodies.
###end p 60
###begin title 61
Statistical analysis
###end title 61
###begin p 62
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Grouped results from at least four different mice were expressed as means +/- SEM. Data were analyzed using statistical analysis software (Statistical Analysis Software Institute). Results grouped by time point and genotype were analyzed using two-way analysis of variance. When significant main effects were detected (P < 0.05), Fisher's least significant difference test was used to determine the differences between groups. A p-value of 0.05 was considered to indicate statistical significance.
###end p 62
###begin p 63
We thank J. Rir-Sim-Ah for technical assistance in selected experiments.
###end p 63
###begin p 64
These studies were supported by grants from the National Institutes of Health (HL68111 and ES09237) and the University of New Mexico General Clinical Research Center (National Institutes of Health National Center for Research Resources General Clinical Research Center 5MO1 RR099).
###end p 64

